Sign in
4

Changes in Ownership

Inmune Bio, Inc. Filed Acc 0001213900-22-014499

Director acquired 17,793 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ganjei James Kelly Director 2022-03-22 Grant or award +17,793 $8.43 $149,995 17,793 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Ganjei James Kelly Director 2022-03-21 Grant or award · Option (right to buy) +35,000 35,000 D: show line 2 in the form
Loading xslF345X03/ownership.xml…